iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS)

CUSIP: 46565G104

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
10,000
Total 13F shares
35,981,503
Share change
-205,929
Total reported value
$488,850,445
Put/Call ratio
192%
Price per share
$13.61
Number of holders
149
Value change
-$5,820,065
Number of buys
69
Number of sells
74

Quarterly Holders Quick Answers

What is CUSIP 46565G104?
CUSIP 46565G104 identifies ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q1 2023

As of 31 Mar 2023, iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) was held by 149 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,981,503 shares. The largest 10 holders included BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, Boxer Capital, LLC, STATE STREET CORP, BVF INC/IL, VANGUARD GROUP INC, BIOIMPACT CAPITAL LLC, CITADEL ADVISORS LLC, and Candriam S.C.A.. This page lists 150 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.